WHWK
HEALTHCAREWhitehawk Therapeutics Inc
$4.15-0.06 (-1.43%)LIVE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving WHWK Today?
No stock-specific AI insight has been generated for WHWK yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.57$4.48
$4.15
Fundamentals
Market Cap$205M
P/E Ratio—
EPS$-0.33
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-2.9%
Debt / Equity—
Trading
Volume147K
Avg Volume (10D)—
Shares Outstanding49.4M
WHWK News
20 articles- Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent HighlightsYahoo Finance·May 7, 2026
- Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026Yahoo Finance·Apr 19, 2026
- Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat SeriesYahoo Finance·Apr 16, 2026
- Discovering Whitehawk Therapeutics Among 3 Promising Penny StocksYahoo Finance·Apr 15, 2026
- Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026Yahoo Finance·Apr 10, 2026
- Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026Yahoo Finance·Mar 17, 2026
- Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent HighlightsYahoo Finance·Mar 12, 2026
- Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027Marketbeat·Mar 10, 2026
- Whitehawk Therapeutics to Participate in Upcoming Investor ConferencesYahoo Finance·Feb 26, 2026
- Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?Yahoo Finance·Feb 18, 2026
- Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences ConferenceYahoo Finance·Feb 18, 2026
- Tempus AI's Key 2025 Milestones Continue to Gain Industry AttentionYahoo Finance·Jan 21, 2026
- Tempus AI (TEM) Soars 15% on $1.1-Billion DealYahoo Finance·Jan 13, 2026
- Tempus Achieves Record Total Contract Value Exceeding $1.1 BillionYahoo Finance·Jan 11, 2026
- Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016Yahoo Finance·Jan 8, 2026
- Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical OfficerYahoo Finance·Dec 1, 2025
- Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare ConferenceYahoo Finance·Nov 26, 2025
- Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in LondonYahoo Finance·Nov 11, 2025
- Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent HighlightsYahoo Finance·Nov 6, 2025
- Hedge funds investors own a significant stake of 37% in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK)Yahoo Finance·Nov 1, 2025
All 20 articles loaded
Price Data
Open$4.24
Previous Close$4.21
Day High$4.27
Day Low$4.13
52 Week High$4.48
52 Week Low$1.57
52-Week Range
$1.57$4.48
$4.15
Fundamentals
Market Cap$205M
P/E Ratio—
EPS$-0.33
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-2.9%
Debt / Equity—
Trading
Volume147K
Avg Volume (10D)—
Shares Outstanding49.4M
About Whitehawk Therapeutics Inc
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—